Compare Nuvalent Inc (NUVL) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Verisign, Inc. — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is far larger — about 2.6× Nuvalent Inc's market cap, and Verisign, Inc. pays a 1.17% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | VRSN | |
|---|---|---|
Market Cap | $9.81B | $25.26B |
Sector | Technology | Technology |
52-Week High | $123.96 | $310.00 |
52-Week Low | $72.16 | $211.49 |
Enterprise Value | $8.52B | $26.50B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
